Abiopharma

New Form NPORT-P - COHEN & STEERS QUALITY INCOME REALTY FUND INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001410368-26-088059 <b>Size:</b> 301 KB

New Form NPORT-P - COHEN & STEERS REIT & PREFERRED & INCOME FUND INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001410368-26-088058 <b>Size:</b> 471 KB

New Form NPORT-P - COHEN & STEERS TOTAL RETURN REALTY FUND INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001410368-26-088051 <b>Size:</b> 266 KB

New Form NPORT-P - Cohen & Steers Real Estate Opportunities & Income Fund <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001410368-26-088050 <b>Size:</b> 319 KB

New Form NPORT-P - COHEN & STEERS INFRASTRUCTURE FUND INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001410368-26-088060 <b>Size:</b> 407 KB

Warrants Listing - Structured Warrants: Proposed Issue of Put Warrants

Pigott, Thomas K. 🟡 adjusted position in 728 shares of MARZETTI CO (MZTI) at $116.05 Transaction Date: Aug 25, 2026 | Filing ID: 007349

Warrants Listing - Structured Warrants: Proposed Issue of Call Warrants

(99% Neutral) BIOXCEL THERAPEUTICS, INC. (BTAI) Announces Business Combination

BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals

Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome

Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Immuron Reports FY26 Preliminary Results

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million